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Dental Mesenchymal Stem Cells Encapsulated in Alginate Hydrogel Co-Delivery
Microencapsulation System for Cartilage Regeneration
Abstract
Dental-derived MSCs are promising candidates for cartilage regeneration, with high chondrogenic
differentiation capacity. This property contributes to making dental MSCs an advantageous therapeutic
option compared to current treatment modalities. The MSC delivery vehicle is the principal determinant
for the success of MSC-mediated cartilage regeneration therapies. The objectives of this study were to:
(1) develop a novel co-delivery system based on TGF-β1 loaded RGD-coupled alginate microspheres
encapsulating Periodontal Ligament Stem Cells (PDLSCs) or Gingival Mesenchymal Stem Cells (GMSCs);
and (2) investigate dental MSC viability and chondrogenic differentiation in alginate microspheres. The
results revealed the sustained release of TGF-β1 from the alginate microspheres. After 4 weeks of
chondrogenic differentiation in vitro, PDLSCs, GMSCs as well as human bone marrow mesenchymal stem
cells (hBMMSC) (as positive control) revealed chondrogenic gene expression markers (Col II and Sox-9)
via qPCR, as well as matrix positively stained by toluidine blue and safranin-O. In animal studies, ectopic
cartilage tissue regeneration was observed inside and around the transplanted microspheres, confirmed
by histochemical and immunofluorescent staining. Interestingly, PDLSCs showed more chondrogenesis
than GMSCs and hBMMSCs (P
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Dental mesenchymal stem cells encapsulated in alginate
hydrogel co-delivery microencapsulation system for cartilage
regeneration
Alireza Moshaverinia, DDS, MS, PhD*, Xingtian Xu, DDS, Chider Chen, BSc, MSc, Kentaro
Akiyama, DDS, PhD, Malcolm L Snead, DDS, PhD, and Songtao Shi, DDS, PhD
Center for Craniofacial Molecular Biology, Ostrow School of Dentistry, University of Southern
California, Los Angeles, CA

Abstract
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Dental-derived MSCs are promising candidates for cartilage regeneration, with high chondrogenic
differentiation capacity. This property contributes to making dental MSCs an advantageous
therapeutic option compared to current treatment modalities. The MSC delivery vehicle is the
principal determinant for the success of MSC-mediated cartilage regeneration therapies. The
objectives of this study were to: (1) develop a novel co-delivery system based on TGF-β1 loaded
RGD-coupled alginate microspheres encapsulating Periodontal Ligament Stem Cells (PDLSCs) or
Gingival Mesenchymal Stem Cells (GMSCs); and (2) investigate dental MSC viability and
chondrogenic differentiation in alginate microspheres. The results revealed the sustained release of
TGF-β1 from the alginate microspheres. After 4 weeks of chondrogenic differentiation in vitro,
PDLSCs, GMSCs as well as human bone marrow mesenchymal stem cells (hBMMSC) (as
positive control) revealed chondrogenic gene expression markers (Col II and Sox-9) via qPCR, as
well as matrix positively stained by toluidine blue and safranin-O. In animal studies, ectopic
cartilage tissue regeneration was observed inside and around the transplanted microspheres,
confirmed by histochemical and immunofluorescent staining. Interestingly, PDLSCs showed more
chondrogenesis than GMSCs and hBMMSCs (P<0.05). Taken together, these results suggest that
RGD-modified alginate microencapsulating dental MSCs make a promising candidate for
cartilage regeneration. Our results highlight the vital role played by the microenvironment, as well
as value of presenting inductive signals for viability and differentiation of MSCs.
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Several treatment modalities have been introduced to regenerate or enhance the repair of
articular cartilage, such as the grafting of autologous osteochondral tissue or the
transplantation of autologous chondrocyte suspensions [1,2]. However, each of these
strategies, the biological and mechanical properties of the formed tissue are inferior to those
of native articular cartilage [3]. An advantageous alternative therapeutic option is
regeneration of cartilage tissue using mesenchymal stem cells (MSCs). MSCs are
multipotent cells that can differentiate into multiple lineages depending on the nature of the
environmental signals which they receive. Specifically, MSCs undergo chondrogenesis and
deposit a cartilage-specific matrix in pellet cultures and in a variety of biomaterials in the
presence of appropriate growth factors. Most of the studies on chondrogenic differentiation
have focused on applications using bone marrow MSCs (BMMSCs). However, it is well
known that MSCs reside in a wide spectrum of post-natal tissue types including the orofacial
tissues [4–6], while neural crest origin are attractive for craniofacial regenerative strategies
as they might be more plastic to differentiate into craniofacial tissues [5–7]. Among the
dental-derived MSCs, periodontal ligament stem cells (PDLSCs) and gingival mesenchymal
stem cells (GMSCs) are of particular interest as they can be harvested easily, accessible
through oral cavity and they can often be obtained as discarded biological samples in dental
clinics [8,9]. Moreover, both in vitro and in vivo studies have confirmed the multilineage
differentiation capabilities of these dental-derived MSCs [10,11].
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However, an appropriate microenvironment and signaling molecules are required in order to
effectively differentiate MSCs into chondrocytes [12]. It has been reported that growth
factors such as: TGF-β1, BMP-4, and FGF-2 are often required in the process of
chondrogenesis [13]. Particularly, studies have reported that transforming growth factor-beta
(TGF-β) plays an important role in chondrogenesis of MSCs [14] by stimulating
chondrocyte proliferation while preventing cartilage hypertrophy [15]. In addition, it is well
known that the cell delivery vehicle has an important role in the in vivo performance of
MSCs and the success of the regenerative therapy. Therefore, we sought to design an
appropriate microenvironment by engineering the physiochemical properties of the
extracellular MSC microenvironment in order to tailor the niche characteristics and direct
cell phenotype through differentiation [16,17]. Hydrogel biomaterials have been widely used
for cartilage tissue engineering. Among the hydrogel biomaterials, alginates, which are
natural hetero-polysaccharides isolated from brown sea algae, are of particular interest due
to their unique properties including injectability and biodegradability [18,19]. Alginate can
provide a 3D scaffold that facilitates the spatial distribution of MSCs, thus resulting in a
structural organization that resembles the native in vivo microenvironments. Moreover,
alginate microspheres have been used extensively for controlled delivery of growth factors
(e.g. TGF-β) making them desirable biomaterials for chondrogenesis [20,21]. In the present
study, we developed a novel co-delivery system that provides a 3D architecture of RGDcoupled alginate hydrogel loaded with a TGF-β1 ligand based for microencapsulation of
dental MSCs. This approach ensures optimized cartilage regeneration and provides a
potential application for reconstruction of the temporomandibular joint disk and for
applications in the appendicular skeleton.

2. Materials and methods
All the animal experiments in the current study were performed in accordance with the
guidelines published by the Institutional Animal Care and Use Committee at the University
of Southern California, and the American Association for Accreditation of Laboratory
Animal Care.
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2.1. Progenitor cell isolation and culture
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Human PDLSCs and GMSCs were isolated and cultured according to previously published
protocols by Seo et al. and Zhang et al. [9, 10]. The teeth and gingival tissues were obtained
from healthy male patients (18–25 years old) undergoing third molar extractions according
to IRB approval from the University of Southern California. Only subjects without any
history of periodontal disease were included in this study.
For assay of colony forming units-fibroblastic (CFU-F), 0.1 × 106 cells were seeded in a
culture dish and cultured for 14 days. Subsequently, the cells were stained with Toluidine
Blue. A cell count of more than 50 in one colony was counted as a positive CFU-F. Passage
4 cells were used in the experiments and hBMMSCs were used as the positive control group.
2.2. Flow cytometric analysis
Approximately 5 × 105 cells at passage four were incubated with specific PE- or FITCconjugated mouse monoclonal antibodies for human CD34 and CD45 (as negative: markers
for hematopoietic stem cells); and CD73, CD105, CD 146, and CD 166 (as positive: markers
for mesenchymal stem cells) (BD Biosciences, San Jose, CA), or isotype-matched control
IgGs (Southern Biotechnology Associates, Birmingham, Alabama) and subjected to flow
cytometric analysis using a Beckman Coulter flow cytometer (Beckman Coulter, Brea, CA)
and analyzed using FACScan software (BD Biosciences).
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2.3. Biomaterial fabrication and cell encapsulation
Custom-made RGD-coupled alginate with high guluronic acid content (NovaMatrix FMC
Biopolymer, Norway) was utilized in this study. Alginate was purified and partially oxidized
(2%) to increase its degradability according to the methods in the literature [22, 23].
Subsequently, the alginate was mixed with TGF-β1 (Abcam, Cambridge, MA) (50 μg/mL)
under rigorous stirring, concentrated, and freeze-dried under reduced pressure.
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PDLSC, GMSC, as well as hBMMSC (as a positive control) were encapsulated in TGF-β1
ligand (50 μg/mL) loaded alginate at a density of 2×106 cells/mL of alginate solution [24].
Microbead formation was accomplished using a microfluidic device with a two-channel
fluid jacket microencapsulator equipped with a micropipette. Alginate (200 μLh−1) and
soybean oil (10 mLh−1) (Sigma) were injected into the device using syringe pumps. Alginate
droplets were sheared off by the soybean oil, flowed out of the device, and were added
dropwise into a petri dish containing 100 mM CaCl2 solution to form microspheres. The
formed constructs were incubated at 37°C for 45 min to complete cross-linking and then
washed three times in non-supplemented DMEM. Alginate hydrogel without cells was used
as the negative control in this study.
2.4. In vitro release study
TGF-β1 (50 μg/mL) loaded alginate microspheres were incubated in 500 mL of highglucose DMEM supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin in 48well plates on a rotational shaker at 37°C for one week. At each selected time interval, the
medium was collected and analyzed for released TGF-β1 using an anti-human recombinant
TGF-β1 ELISA kit (Abcam). At the end of release study, the residual entrapped TGF-β1 was
extracted by dissolving the scaffolds in 10% sodium citrate solution in distilled water and
the percentage of cumulative released TGF-β1 was measured.
2.5. Cell survival assay
Survival of the encapsulated MSCs was measured as described previously [22, 23] using
calcein AM to stain live cells and ethidium bromide homodimer-1 to stain dead cells
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(Invitrogen, Carlsbad, CA). The percentage of live cells was measured using ImageJ
software. Additionally, an MTT assay (Invitrogen) was utilized to further evaluate the
metabolic activity of encapsulated MSCs according to methods previously published [25].
2.6. In vitro chondrogenic assay
Encapsulated PDLSCs and GMSCs as well as hBMMSCs (2×106 in 1 mL of alginate) were
cultured with a chondrogenic medium containing DMEM with 15% FBS, 2 mM Lglutamine, 1% ITS (BD Bioscience), 100 nM Dex, 100 μM ascorbic acid, 2 mM sodium
pyruvate (R&D Systems, Minneapolis, MN), 100 U/mL penicillin, and 100 μg/mL
streptomycin.
Four weeks after the induction, the samples were fixed with 4% PFA, and paraffin sections
were made. Chondrogenic differentiation, as indicated by matrix production, was
determined by staining with 0.1% safranin-O (Sigma-Aldrich, St. Louis, MO) and 0.1%
toluidine blue (Sigma-Aldrich) solution. Because the polyanions of alginate stained
intensely by Safranin-O and toluidine blue resulted in a strong background, the sections
were first washed with Ca2+-free PBS to remove the cross-linker Ca2+ and dissociate the
alginate prior to staining.

NIH-PA Author Manuscript

Sections were immunolabeled using primary Sox 9 and Collagen II antibodies (Abcam) at
4°C overnight, detected using Alexa fluor conjugated secondary antibody (1:200 dilution;
Invitrogen), and counterstained with DAPI. The chondrogenic assays were determined from
3 independent samples for each experimental group. Five areas were randomly selected from
each sample, then the positive area in the field was calculated with NIH Image-J software
(NIH, Bethesda, MD) and shown as a percentage of the area over total field area.
2.7. RNA isolation, reverse transcription and real time PCR
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PDLSC, GMSC, as well as hBMMSC were encapsulated in TGF-β1 ligand (50 μg/mL)
loaded alginate in presence or absence of 100 ng/ml human recombinant BMP-4 or 50 μg/
mL FGF2 (both from Invitrogen) as previously described. After 2 weeks of culturing in
chondrogenic media, extraction of RNA from the encapsulated cells was performed by
collecting 10 alginate hydrogels and dissolving them for 15–20 min by gentle stirring in a
sterile depolymerization buffer consisting of 50 mM sodium citrate dehydrate and 80 mM
sodium chloride (Sigma Aldrich, St Louis, MO). Following dissolution, the decapsulated
cells were centrifuged at 9400 g for 10 min and the pellet was washed with PBS and
centrifuged again at 9400 g for 3 min. Total RNA was extracted using Trizol reagent
(Invitrogen) according to the manufacturer’s recommendations. Single-stranded cDNA
synthesis was performed with 100 ng total RNA using a Superscript III cDNA synthesis kit
(Invitrogen). Data were analyzed by the 2−ΔΔCt method, with normalization to the Ct of the
housekeeping gene GAPDH. Primer and probe sequences are described in Table 1.
2.8. Dental MSC-mediated tissue regeneration in vivo
PDLSCs, GMSCs, and hBMMSCs were encapsulated in TGF-β1 loaded alginate systems
and transplanted subcutaneously (approximately 4 × 106 cells) into the dorsal surface of 5month-old Beige nude XID III (NU/NU) mice (Harlan, Livermore, CA; N=5 for each
group). All animals were treated according to the Guidelines and Regulations for the Use
and Care of Animals at University of Southern California. After 8-weeks the mice were
sacrificed, the constructs and the surrounding tissue were surgically removed and analyzed
using histological, histochemical and immunofluorescence staining.
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2.9. Histological and histochemical assessment
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For histological examination, harvested specimens were fixed in 10% formalin solution and
dehydrated in an ascending series of ethanol and embedded in paraffin. Six-micrometer
sections were cut using a microtome and mounted on glass slides. Four randomly selected
cross-sections from each implant were stained with hematoxylin & eosin (H&E).
Additionally, sections were stained with toluidine blue and with Safranin-O to identify
newly synthesized cartilage ECM glycosaminoglycans (GAGs) Five areas were randomly
selected from each sample, and the positive area in the field was calculated with Image-J
software and shown as a percentage of the area over total field area.
2.10. Immunohistochemical and Immunofluorescence staining
For immunohistochemical analysis, the animals were scarified three weeks after
transplantation and harvested specimens were prepared according to the abovementioned
method. The de-paraffinized sections were washed, and non-specific endogenous peroxidase
activity was quenched by immersing in 3% H2O2/methanol for 15 min. Sections were
incubated with primary antibody (1:200–1:300 dilution) for 1 h. Immunohistochemistry
examination was performed on sections using anti-BMP4 (Abcam, 1:200 dilution) and antiFGF-2 (Abcam, 1:100 dilution) and counterstaining with hematoxylin.
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For immunofluorescence staining, samples (retrieved after eight weeks of transplantation)
were treated with 3% H2O2, followed by a blocking buffer (1% BSA and 0.25% Triton
X-100 in PBS). Samples were then incubated with mouse anti-rabbit collagen II
(Calbiochem, San Diego, CA) and Sox 9 (Abcam) antibodies at a dilution of 1:100 and
detected using Alexa Fluor conjugated secondary antibody (1:200 dilution; Invitrogen). The
samples were then counterstained with DAPI.
2.11. Statistical Analysis
Data were analyzed using an independent two–tailed Student’s t-test or analysis of variance
(ANOVA) (α<0.05). The numerical data are presented as the mean ± SD.

3. Results
3.1. In vitro characterization of dental-derived MSCs
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In this study the CFU-F assay was performed to assess the colony-forming ability of the
newly isolated stem cells. PDLSCs and GMSCs showed significantly higher numbers of
single-colony clusters (CFU-F) compared to hBMMSCs (Fig. 1a). Next, in order to identify
whether the isolated cells were MSC-like, FACS analysis was performed and demonstrated
that human PDLSCs and GMSCs display specific MSC markers such as CD 73, CD 105 CD
146, and CD 166, while not expressing hematopoietic lineage markers such as CD 34 and
CD 45 (Fig. 1b). These data confirmed the stem cell properties for each of these types of
dental-derived MSCs.
3.2. Alginate microspheres as a drug delivery vehicle that maintains MSC viability
An alginate microencapsulation system was developed in this study in order to induce
cartilage differentiation of PDLSCs and GMCSs. As a positive control, hBMMSCs
encapsulated in alginate were used. In the current study, RGD-coupled alginate
microcapsules containing stem cells had an average diameter of 327 μm (Fig 2a).
Microscopic images of stem cells loaded into microcapsules showed a uniform microsphere
size and cell distribution. Fig. 2b represents the cumulative release profile of TGF-β1 from
the RGD-coupled alginate scaffold compared to the alginate scaffold without RGD
tripeptide. The results show sustained release of TGF-β1 for up to 14-days. Also, there was
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no significant difference in release rates from the two scaffolds as a function of time (pvalue >0.05), which both rates showing first-order kinetics.
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A live-dead assay showed a high degree of viability of MSCs in alginate microspheres after
four weeks of in vitro culturing (Fig. 2c). Furthermore, an MTT assay was utilized to
quantitatively measure cytotoxicity and MSC viability in the alginate microencapsulation
system in vitro. All the MSCs-alginate constructs showed high MTT absorbance, indicating
high metabolic activity and viability of the encapsulated stem cells after up to two weeks of
culturing in regular media (Fig. 2d). These results show that the viability of PDLSCs,
GMSCs as well as hBMMSCs were favorably supported in our biodegradable alginate
microspheres. Furthermore, MSCs encapsulated in RGD containing alginate microspheres
showed significantly higher degrees of viability in comparison to MSCs encapsulated in
non-RGD containing alginate microspheres after 14 days of culturing in regular culture
media (supplementary Fig. 1a).
3.3. Chondrogenic differentiation of dental MSCs in vitro
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After four weeks of culturing in chondrogenic induction media, the deposition of
proteoglycans by either PDLSCs or GMSCs in vitro was detected using safranin-O and
toluidine blue staining. Safranin-O staining was positive for PDLSCs and GMSCs, as well
as hBMMSCs (Fig 3a). All the MSCs were also positive for toluidine blue (Fig. 3b). As
expected, MSCs encapsulated in RGD immobilized alginate microspheres exhibited
statistically greater amounts of proteoglycan deposition (by toluidine blue staining) in
comparison to non-RGD immobilized counterparts (supplementary Figs. 1b and 1c).
Additionally, the results of immunofluorescent staining correlated well with the
histochemical staining, showing that all the tested MSCs expressed type II collagen (Col II)
genes as shown by positive immunostaining (Figs. 3c). Interestingly, the semi-quantitative
analysis of the specimens revealed that PDLSCs showed higher amounts of chondrogenesis
than hBMMSCs and GMSCs (P-value <0.05) (Fig. 3e). No significant difference was
observed between GMSCs and hBMMSCs (P>0.05). Subsequently, the expression levels of
the chondrogenic genes (Sox9 and type II collagen) were confirmed and compared via RTPCR. Sox9 is an essential factor for the initiation of the chondrogenic differentiation
pathway leading to a subsequent upregulation of Col II. Sox9 shows the greatest amount of
activity in proliferating chondrocytes. The results showed that all the MSC groups expressed
abundant Col II and Sox 9 (Figs. 4a and b). PDLSCs showed significantly greater expression
levels of Sox9 and Col II than GMSCs and hBMMSC (p<0.05). However, Sox 9 and Col II
gene expression levels were similar between hBMMSCs and GMSCs (P>0.05). Further
supplementation of alginate microspheres with BMP-4 or FGF2 in combination with TGFβ1, slightly increased the expression levels of Sox9 and Col II in comparison to samples
loaded with only TGF-β1 (supplementary Fig. 2).
3.4. Dental MSCs contributed to cartilage tissue regeneration in vivo
The ability of RGD-coupled alginate microspheres loaded with TGF-β1 to support MSC
chondrogenic differentiation was evaluated in an ectopic site after subcutaneous
implantation into nude mice. Toluidine blue and safranin-O staining of matrix confirmed the
chondrogenic differentiation of all the tested MSCs. The cells in these constructs exhibited
the round morphology of committed chondrocytes. By contrast, the control group, with
implants consisting of alginate hydrogel alone, failed to show any of the signs positive for
chondrogenesis (Figs. 5a and b). Immunofluorescent staining for type-II collagen and Sox 9
antibodies after 8-weeks of transplantation revealed extensive production and deposition of
chondrogenic tissues (Figs. 5c and 5d). The production of collagen type II was more
pronounced for PDLSCs than for GMSCs and hBMMSCs (P<0.05) (Fig. 5e), while GMSCs
and hBMMSCs showed the same amounts of chondrogenesis (P<0.05). H&E staining
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results confirmed the presence of large islands of rounded cells with human chondrocytes
morphology in MSC-seeded constructs, which is not found in the cell-free transplants (Fig.
6a). To further characterize MSC-mediated chondrogenesis in vivo, immunohistochemical
staining was utilized. Results revealed detection of BMP-4 and FGF-2 growth factors in the
early stages of chondrogenic differentiation (after three weeks of transplantation),
suggesting the important role of TGF-β1 in the process of chondrogenesis (Figs. 6b and 6c).

4. Discussion
It is well known that the cell delivery vehicle has an important role in the in vivo
performance of stem cells and the success of regenerative therapy [25]. In this study, we
developed an injectable RGD-coupled alginate-hydrogel microsphere as a stem cell delivery
system for potential application in cartilage tissue engineering. We demonstrated that this
system supported the viability, metabolic activity, and chondrogenic differentiation of
encapsulated PDLSCs and GMSCs in vitro and in vivo. More importantly, in the current
study we are introduced PDLSCs and GMSCs for the first time as promising candidates for
optimized cartilage regeneration with potential applications for reconstruction of the
temporomandibular joint (TMJ) disk.
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To our knowledge, the chondrogenesis of dental MSC has not been developed and reported
in an RGD-coupled alginate microencapsulation system before. From a practical
perspective, dental MSCs such as PDLSCs and GMSCs are a superior source of stem cells
considering their accessibility and suitability for autologous transplantation. Studies have
confirmed that both PDL and gingiva contain populations of multipotent postnatal stem cells
that can readily be isolated and expanded in vitro [10,11]. As a result, human PDLSC- or
GMSC-mediated tissue regeneration can be considered as a promising cellular-based
treatment for cartilage tissue engineering. More importantly, considering the neural crest
origin of both dental MSCs and TMJ disk cartilage [26], they can be used as a platform for
functional regeneration of the TMJ disk.
The RGD-coupled-dental MSC system developed in the current study was observed strongly
positively stained by Safranin-O and toluidine blue in vitro and in vivo. We observed the in
vitro positive staining 4 weeks after culturing in chondrogenic culturing media. Furthermore,
immunofluroscent staining demonstrated strong positive reactivity for Col II and Sox 9
antibodies around the cells both in vitro and in vivo. The synthesis of the two main matrices
of articular cartilage, proteoglycan and type II collagen, demonstrates that dental MSCs
embedded in alginate microspheres and induced with the addition of TGF-β1 in the medium,
can effectively undergo chondrogenic differentiation. Furthermore, we report that PDLSCs
have greater chondrogenic differentiation capacity than hBMMSCs.
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The alginate hydrogel microencapsulation system provides a unique 3D cell delivery
scaffold for cartilage tissue engineering. Studies confirm that macromolecules with
molecular weights of less than 49 kDa can penetrate the pores of the alginate hydrogel
microspheres to influence the cell behavior [27]. Therefore, different growth factors and
proteins (e.g. TGF-β1) can enter the microspheres and regulate the proliferation and
differentiation of encapsulated MSCs [28]. This and other advantages make alginate
hydrogel a more desirable scaffold than other polymeric materials, such as polylactic acid,
for cartilage tissue engineering [29]. Alginate hydrogel can be considered a semisolid
structure, where the MSCs assumed a polygonal-rounded morphology with increasing
proteoglycan and type II collagen synthesis [30].
It has been shown that several growth factors and cytokines, such as members of
transforming growth factor superfamily (TGF-β1, and BMP-4), and FGF-2 have important
role in chondrogenic differentiation of MSCs [31, 32]. The results of the current study,
Acta Biomater. Author manuscript; available in PMC 2014 December 01.
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confirmed the importance of presence of these cytokines specifically TGF-β1 in the
chondrogenesis of the encapsulated dental MSCs (Figs. 6b and c) showing that the provided
micro milieu and the initiating signals from TGF-β1 alone might be sufficient to cause
endogenous expression of BMP 4 and FGF 2 that are required for chondrogenesis.
Re’em et al. in their studies, investigated the effects of RGD peptide immobilized onto
alginate scaffolds, on the chondrogenesis of human MSCs in the presence of TGF- β1. Their
results confirmed that immobilized RGD did not interfere with progression of MSCs [19]. In
addition, immobilized RGD considerably encouraged and accelerated the TGF- β 1-induced
chondrogenesis of human MSC encapsulated in alginate scaffolds. We have previously
shown that our prepared alginate scaffold has a porous structure [22] (data not shown here).
This porous structure might have a critical role in the diffusion capacity of oxygen, nutrients
and signaling molecules within the alginate microspheres. Therefore, one can conclude that
cell matrix interactions facilitated by the immobilization of RGD tripeptide onto the alginate
hydrogel scaffold with porous structure can enable the adhesion of encapsulated dentalderived MSCs to the matrix, and permit enhanced cell accessibility to the oxygen, nutrients
and the growth factors (e.g. TGFb1) [20].
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In the current study, stem cells were not cultured in chondrogenic media prior to surgical
transplantation, and encapsulated PDLSCs and GMSCs in alginate microspheres promoted
cartilage regeneration in situ. Chai et al. reported that the articulating disc and TMJ originate
from cranial neural crest (CNC) cells [25]. Taking into account the fact that neural crest is
the same origin of the dental MSCs used in this study, cells recovered from these origins
might be considered as excellent candidates for disc and TMJ regeneration. Therefore, in
future studies, the possibility of utilizing PDLSCs and GMSCs in the repair of cartilage and
disk defects in TMJ in more appropriate animal models will be evaluated. The results of
these endeavors will be reported in due course. More importantly, dental derived MSCs
encapsulated in alginate hydrogel can be considered a promising candidate for appendicular
skeleton repair and regeneration.

6. Conclusions
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Altogether, our findings demonstrate the important role of the microenvironment as well as
the presentation of inductive signals (TGF-β1) for viability and chondro-differentiation of
dental MSCs in an RGD-modified alginate microencapsulation system. Our in vitro and in
vivo studies confirmed that the proposed system comprises a promising model for high
quality cartilage regeneration. We show that RGD-coupled alginate hydrogel can be used to
encapsulate PDLSCs and GMSCs for chondrogenesis in an animal model. The system
developed here has the advantages of providing a simple and readily manipulated means to
encapsulate dental MSCs in RGD-coupled alginate hydrogel, and a 3D, injectable and
biodegradable cell delivery scaffold for cartilage tissue engineering.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Characterization of stem cells used in this study: (a) PDLSCs and GMSCs were able to form
significantly higher numbers of single colonies than BMMSCs (*P < 0.05) when 1× 106
cells were plated at a low density and cultured for 10 days. Single colonies were formed for
PDLSCs, GMSCs as well as hBMMSCs after plating at low density and cultured for 10
days; (b) Expression of cell surface markers on PDLSCs, GMSCs, and hBMMSCs (passage
4) as determined by flow cytometric analysis.
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Figure 2.

NIH-PA Author Manuscript

Development of microenvironment based on TGF-β1-loaded alginate hydrogel: (a)
Microspheres produced by the microfluidic device. The diameter of the microspheres was
between 196 μm and 581 μm (scale bar = 500 μm). (b) Characterization of the in vitro
release profile of TGF-β1 loaded alginate microspheres showing sustained release of TGFβ1 from the RGD-modified alginate and the non-RGD modified alginate microspheres.
Cumulative release is calculated from the total amount of TGF-β1 released after 14-days. (c)
Viability of the encapsulated MSCs: percentage of live cells in RGD-coupled alginate
microspheres. (d) MTT assay to determine the metabolic activity of cells. No significant
difference was observed between MSC groups at each time interval.
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Figure 3.
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Histochemical analysis showed that RGD coupled alginate microspheres promoted spreadout cell morphology. Stem cells and cell aggregates are surrounded by toluidine blue (a) and
Safranin-O (b) and strongly stained matrix, confirming the production and accumulation of
cartilage extracellular matrix. (c) Immunofluorescence staining against collagen type II (Col
II) antibodies confirmed the production and secretion of type-II collagen by PDLSCs and
GMSCs. (d) Analysis of the percentage of cells positive for anti-Col II antibodies, showing
that PDLSCs encapsulated in RGD coupled alginate presented the greatest amounts of
production and secretion of collagen type II in comparison to GMSCs and hBMMSCs.
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Figure 4.
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Expression level (in fold changes) of collagen type II (a) and Sox-9 (b) genes for each
encapsulated stem cell population after 2-weeks of chondro-differentiation in vitro evaluated
by RT-PCR. Data were normalized by the Ct of the housekeeping gene GAPDH and
expressed relatively to gene expression level at day 1. *P <0.05, NS: not significant.
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Figure 5.

Chondrogenesis in TGF-β1 loaded alginate subcutaneously transplanted in nude mice. MSCconstructs were removed eight weeks after transplantation, sectioned, and stained with
Safranin-O (a) and toluidine blue (b). Immunofluorescence staining, using antibodies against
collagen type II (c) and Sox-9 (d) antibodies confirmed the production and secretion of typeII collagen. (e) Semi-quantitative analysis of the percentage of cells positive for anti-Sox9
antibodies via immunofluorescence staining images. *P <0.05, NS: not significant.
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Figure 6.

In vivo chondrogenic differentiation after subcutaneous transplantation in nude mice: (a)
H&E staining showing presence of large islands of rounded cells with human chondrocytes
morphology in MSC-seeded constructs, while (−) is the unseeded alginate scaffold.
Immunohistochemical staining in specimens retrieved three weeks after transplantation
showing positive results (red arrows) for anti-BMP-4 (b) and anti-FGF-2 (c) antibody
staining, while negative control (−) failed to express any positive staining (Alg: unresorbed
alginate scaffold).
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Table 1

Oligonucleotide primers used in RT-PCR analysis.
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Gene

Sequence

Amplication (bp)

Sox 9

Sense: 5′-ACGCCGAGCTCAGCAAGA-3′
Antisense: 5′-CACGAAGGGCCGCTTCT-3′

289

Collagen II

Sense: 5′-GGCAATAGCAGGTTCACGTACA-3′;
Antisense: 5′-CGATAACAGTCTTGCCCCACTT-3′

827

Glyceraldehyde 3-phosphate dehydrogenase (GADPH)

Sense: 5′-AGCCGCATCTTCTTTTGCGTC-3′:
Antisense: 5′-TCATATTTGGCAGGTTTTT CT-3′

418
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